Neuro-Oncology Reviews

Volume 25 Number 9
15 May 2023

Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 9, 15 May


Fernandes RT, Teixeira GR, Mamere EC, Bandeira GA, Mamere AE.
The 2021 World Health Organization classification of gliomas: an imaging approach.
Radiol Bras. 2023 May-Jun;56(3):157-161
. doi: 10.1590/0100-3984.2022.0089-en. PMID: 37564083. Pictorial essay. ˍ

McCornack C, Woodiwiss T, Hardi A, Yano H, Kim AH.
The function of histone methylation and acetylation regulators in GBM pathophysiology.
Front Oncol. 2023 May 2;13:1144184. doi: 10.3389/fonc.2023.1144184. PMID: 37205197. Review. ˍ

Meng Y, Sun J, Zhang G, Yu T, Piao H.
Bacteria associated with glioma: a next wave in cancer treatment.
Front Cell Infect Microbiol. 2023 May 2;13:1164654. doi: 10.3389/fcimb.2023.1164654. PMID: 37201117. Review. ˍ

Dillman RO, Nistor GI, Keirstead HS.
Autologous dendritic cells loaded with antigens from self-renewing autologous tumor cells as patient-specific therapeutic cancer vaccines.
Hum Vaccin Immunother. 2023 May 3:2198467. doi: 10.1080/21645515.2023.2198467. PMID: 37133853. Review. ˍ

Khatami SH, Karami N, Taheri-Anganeh M, Taghvimi S, Tondro G, Khorsand M, Soltani Fard E, Sedighimehr N, Kazemi M, Rahimi Jaberi K, Moradi M, Nafisi Fard P, Darvishi MH, Movahedpour A.
Exosomes: Promising Delivery Tools for Overcoming Blood-Brain Barrier and Glioblastoma Therapy.
Mol Neurobiol. 2023 May 3:1–20. doi: 10.1007/s12035-023-03365-0. PMID: 37138197. Review. ˍ

Murdaugh RL, Anastas JN.
Applying single cell multi-omic analyses to understand treatment resistance in pediatric high grade glioma.
Front Pharmacol. 2023 May 3;14:1002296. doi: 10.3389/fphar.2023.1002296. PMID: 37205910. Review. ˍ

Zhang Q, Wang J, Zhang J, Liu F.
Potential functions and therapeutic implications of glioma-resident mesenchymal stem cells.
Cell Biol Toxicol. 2023 May 3. doi: 10.1007/s10565-023-09808-7. PMID: 37138122. Review˰ ˍ

de Biase D, Franceschi E, Marucci G.
Editorial: Advances in brain tumors diagnosis and treatment.
Front Med (Lausanne). 2023 May 4;10:1152547. doi: 10.3389/fmed.2023.1152547. PMID: 37215713. Editorial. ˍ

Padmakumar S, Amiji MM.
Long-Acting Therapeutic Delivery Systems for the Treatment of Gliomas.
Adv Drug Deliv Rev. 2023 May 4:114853. doi: 10.1016/j.addr.2023.114853. PMID: 37149040. Review˰ ˍ

Shi T, Zhu J, Zhang X, Mao X.
The Role of Hypoxia and Cancer Stem Cells in Development of Glioblastoma.
Cancers (Basel). 2023 May 4;15(9):2613. doi: 10.3390/cancers15092613. PMID: 37174078. Review. ˍ

Henssen D, Leijten L, Meijer FJA, van der Kolk A, Arens AIJ, Ter Laan M, Smeenk RJ, Gijtenbeek A, van de Giessen EM, Tolboom N, Oprea-Lager DE, Smits M, Nagarajah J.
Head-To-Head Comparison of PET and Perfusion Weighted MRI Techniques to Distinguish Treatment Related Abnormalities from Tumor Progression in Glioma.
Cancers (Basel). 2023 May 5;15(9):2631. doi: 10.3390/cancers15092631. PMID: 37174097. Review. ˍ

Sun W, Song C, Tang C, Pan C, Xue P, Fan J, Qiao Y.
Performance of deep learning algorithms to distinguish high-grade glioma from low-grade glioma: A systematic review and meta-analysis.
iScience. 2023 May 5;26(6):106815. doi: 10.1016/j.isci.2023.106815. PMID: 37250800. Review, Meta-analysis. ˍ

Wei D, Zhang N, Qu S, Wang H, Li J.
Advances in nanotechnology for the treatment of GBM.
Front Neurosci. 2023 May 5;17:1180943. doi: 10.3389/fnins.2023.1180943. PMID: 37214394. Review. ˍ

Iturrioz-Rodríguez N, Sampron N, Matheu A.
Current advances in temozolomide encapsulation for the enhancement of glioblastoma treatment.
Theranostics. 2023 May 8;13(9):2734-2756. doi: 10.7150/thno.82005. PMID: 37284445. Review. ˍ

Lassaletta Á, Morales JS, Valenzuela PL, Esteso B, Kahalley LS, Mabbott DJ, Unnikrishnan S, Panizo E, Calvo F.
Neurocognitive outcomes in pediatric brain tumors after treatment with proton versus photon radiation: a systematic review and meta-analysis.
World J Pediatr. 2023 May 8. doi: 10.1007/s12519-023-00726-6. PMID: 37154861. Review, Meta-analysis. ˍ

Liu C, Kuang S, Wu L, Cheng Q, Gong X, Wu J, Zhang L.
Radiotherapy and radio-sensitization in H3K27M-mutated diffuse midline gliomas.
CNS Neurosci Ther. 2023 May 8. doi: 10.1111/cns.14225. PMID: 37157237. Review. ˍ

Sim HW, Lorrey S, Khasraw M.
Advances in Treatment of Isocitrate Dehydrogenase (IDH)-Wildtype Glioblastomas.
Curr Neurol Neurosci Rep. 2023 May 8. doi: 10.1007/s11910-023-01268-0. PMID: 37154886. Review˰ ˍ

Elshaer SS, Abulsoud AI, Fathi D, Abdelmaksoud NM, Zaki MB, El-Mahdy HA, Ismail A, Elsakka EGE, Abd-Elmawla MA, Abulsoud LA, Doghish AS.
miRNAs role in glioblastoma pathogenesis and targeted therapy: Signaling pathways interplay.
Pathol Res Pract. 2023 May 9;246:154511. doi: 10.1016/j.prp.2023.154511. PMID: 37178618. Review˰ ˍ

Meldolesi J.
Role of Senescent Astrocytes in Health and Disease.
Int J Mol Sci. 2023 May 9;24(10):8498. doi: 10.3390/ijms24108498. PMID: 37239843. Review. ˍ

Segura-Collar B, Hiller-Vallina S, de Dios O, Caamaño-Moreno M, Mondejar-Ruescas L, Sepulveda-Sanchez JM, Gargini R.
Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators.
Acta Neuropathol Commun. 2023 May 10;11(1):79. doi: 10.1186/s40478-023-01569-y. PMID: 37165457. Review. ˍ

Sharma N, Mallela AN, Shi DD, Tang LW, Abou-Al-Shaar H, Gersey ZC, Zhang X, McBrayer SK, Abdullah KG.
Isocitrate dehydrogenase mutations in gliomas: A review of current understanding and trials.
Neurooncol Adv. 2023 May 10;5(1):vdad053. doi: 10.1093/noajnl/vdad053. PMID: 37287696. Review. ˍ

Guo X, Sui R, Piao H.
Exosomes-mediated crosstalk between glioma and immune cells in the tumor microenvironment.
CNS Neurosci Ther. 2023 May 11. doi: 10.1111/cns.14239. PMID: 37170647. Review. ˍ

Li S, Dong L, Pan Z, Yang G.
Targeting the neural stem cells in subventricular zone for the treatment of glioblastoma: an update from preclinical evidence to clinical interventions.
Stem Cell Res Ther. 2023 May 11;14(1):125. doi: 10.1186/s13287-023-03325-4. PMID: 37170286. Review. ˍ

Porter AB, Wen PY, Polley MC.
Molecular Profiling in Neuro-Oncology: Where We Are, Where We're Heading, and How We Ensure Everyone Can Come Along.
Am Soc Clin Oncol Educ Book. 2023 May 11;43:e389322. doi: 10.1200/EDBK_389322. PMID: 37167580. Review. ˍ
Erratum in: Am Soc Clin Oncol Educ Book. 2023 Jun 30;43:e389322CX1. doi: 10.1200/EDBK_389322CX1. PMID: 37390390. Correction. ˍ

Srivastava R, Dodda M, Zou H, Li X, Hu B.
Tumor niches: perspectives for targeted therapies in glioblastoma.
Antioxid Redox Signal. 2023 May 11. doi: 10.1089/ars.2022.0187. PMID: 37166370. Review˰ ˍ

Alfonso-Triguero P, Lorenzo J, Candiota AP, Arús C, Ruiz-Molina D, Novio F.
Platinum-Based Nanoformulations for Glioblastoma Treatment: The Resurgence of Platinum Drugs?
Nanomaterials (Basel). 2023 May 12;13(10):1619. doi: 10.3390/nano13101619. PMID: 37242036. Review. ˍ

Kumari S, Gupta R, Ambasta RK, Kumar P.
Multiple therapeutic approaches of glioblastoma multiforme: From terminal to therapy.
Biochim Biophys Acta Rev Cancer. 2023 May 12:188913. doi: 10.1016/j.bbcan.2023.188913. PMID: 37182666. Review˰ ˍ

Mofatteh M, Mashayekhi MS, Arfaie S, Chen Y, Malhotra AK, Alvi MA, Sader N, Antonick V, Fatehi Hassanabad M, Mansouri A, Das S, Liao X, McIntyre RS, Del Maestro R, Turecki G, Cohen-Gadol AA, Zadeh G, Ashkan K.
Suicidal ideation and attempts in brain tumor patients and survivors: A systematic review.
Neurooncol Adv. 2023 May 12;5(1):vdad058. doi: 10.1093/noajnl/vdad058. PMID: 37313501. Review. ˍ

Norris JN, Waack AL, Becker KN, Keener M, Hoyt A, Reinard K.
Glioblastoma in pregnant patient with pathologic and exogenous sex hormone exposure and family history of high-grade glioma: A case report and review of the literature.
Surg Neurol Int. 2023 May 12;14:169. doi: 10.25259/SNI_58_2023. PMID: 37292394. Case report, Review. ˍ

Starup-Hansen J, Williams SC, Funnell JP, Hanrahan JG, Islam S, Al-Mohammad A, Hill CS.
Optimising trajectory planning for stereotactic brain tumour biopsy using artificial intelligence: a systematic review of the literature.
Br J Neurosurg. 2023 May 13:1-10. doi: 10.1080/02688697.2023.2210225. PMID: 37177983. Review˰ ˍ

Bonosi L, Marino S, Benigno UE, Musso S, Buscemi F, Giardina K, Gerardi R, Brunasso L, Costanzo R, Iacopino DG, Maugeri R.
Sonodynamic therapy and magnetic resonance-guided focused ultrasound: new therapeutic strategy in glioblastoma.
J Neurooncol. 2023 May 14. doi: 10.1007/s11060-023-04333-3. PMID: 37179515. Review. ˍ

Ceccarelli M.
Editorial: Cerebellar development and medulloblastoma: new players and therapeutic options.
Front Cell Dev Biol. 2023 May 15;11:1214635. doi: 10.3389/fcell.2023.1214635. PMID: 37255598. Review. ˍ

Eraky AM, Beck RT, Treffy RW, Aaronson DM, Hedayat H.
Role of Advanced MR Imaging in Diagnosis of Neurological Malignancies: Current Status and Future Perspective.
J Integr Neurosci. 2023 May 15;22(3):73. doi: 10.31083/j.jin2203073. PMID: 37258452. Review. ˍ

Yao B, Delaidelli A, Vogel H, Sorensen PH.
Pediatric Brain Tumours: Lessons from the Immune Microenvironment.
Curr Oncol. 2023 May 15;30(5):5024-5046. doi: 10.3390/curroncol30050379. PMID: 37232837. Review. ˍ